The role of molecular genetic alterations in sensitivity of the adjuvant intravesical therapy for non-muscle invasive bladder cancer

D. S. Mikhaylenko; S. A. Sergienko; I. N. Zaborsky; K. N. Saflullin; S. A. Serebryany; N. Yu. Safronova; M. V. Nemtsova; A. D. Kaprin; B. Ya. Alekseev

Cancer Urology
Onkourologiâ

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

User

eng | рус

Cancer Urology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Mikhaylenko D.S., Sergienko S.A., Zaborsky I.N., Saflullin K.N., Serebryany S.A., Safronova N.Yu., Nemtsova M.V., Kaprin A.D., Alekseev B.Ya. The role of molecular genetic alterations in sensitivity of the adjuvant intravesical therapy for non-muscle invasive bladder cancer. Cancer Urology. 2018;14(4):124-138. (In Russ.) https://doi.org/10.17650/1726-9776-2018-14-4-124-138

Views PDF (Rus): 877

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Boris Ya. Alekseev

About the Authors

D. S. Mikhaylenko
N.A. Lopatkin Research Institute of Urology and Interventional Radiology — branch of the National Medical Research Radiological Center, Ministry of Health of Russia; Sechenov First Moscow State Medical University, Ministry of Health of Russia; Research Centre for Medical Genetics
Russian Federation

Build. 1, 51 3^rdParkovaya St., Moscow 105425; Build. 2, 8 Trubetskaya St., Moscow 119991; 1 Moskvorechye St., Moscow 115522.

S. A. Sergienko
N.A. Lopatkin Research Institute of Urology and Interventional Radiology — branch of the National Medical Research Radiological Center, Ministry of Health of Russia
Russian Federation